Integra Lifesciences Holdings (IART) Current Deferred Tax Assets (2009 - 2015)

Integra Lifesciences Holdings has reported Current Deferred Tax Assets for 7 years, with the latest figure at $46.9 million in Q3 2015.

• Quarterly Current Deferred Tax Assets rose 5.92% year-over-year to $46.9 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $46.9 million (up 5.92% YoY) and the FY2014 annual result came in at $30.6 million, down 37.13% from the prior year.
• Current Deferred Tax Assets slipped to $46.9 million in Q3 2015 per IART's latest filing, from $58.2 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $64.6 million in Q3 2012 and troughed at $30.6 million in Q4 2014.
• A 5-year average of $44.6 million and a median of $40.0 million in 2013 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2012 and 2013: Current Deferred Tax Assets jumped 77.53% in 2012, then slumped 38.78% in 2013.
• Over 5 years, Current Deferred Tax Assets stood at $36.2 million in 2011, then grew by 8.15% to $39.1 million in 2012, then rose by 24.34% to $48.6 million in 2013, then plunged by 37.13% to $30.6 million in 2014, then jumped by 53.44% to $46.9 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $46.9 million, $58.2 million, and $58.3 million for Q3 2015, Q2 2015, and Q1 2015 respectively.